$10.37
0.363.6%
Last update: Nov 11, 6:03 PM
MiNK Therapeutics Inc (INKT) Stock Price, Quote, News & History
INKTNASDAQ
MiNK Therapeutics (NASDAQ:INKT) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.
Other companies in MiNK Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
MiNK Therapeutics has a consensus price target of $40.75.
The stock price for MiNK Therapeutics (NASDAQ: INKT) is $10.22 last updated November 11, 2026 at 6:03 PM EST.
There are no upcoming dividends for MiNK Therapeutics.
MiNK Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for MiNK Therapeutics.
MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated...
